Cases & Deals

Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Mylan

Clients Purdue Pharma L.P.

Jones Day successfully represented Purdue Pharma L.P. in a Hatch-Waxman patent infringement action against defendants, relating to the defendants' submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of OxyContin®, a widely prescribed treatment for pain relief. Purdue came to a successful resolution of the dispute through settlement.

Purdue Pharma et al. v. Mylan Pharmaceuticals Inc., et al., Case No. 1:15-cv-01155-SLR (D. Del.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.